Expanded prostate cancer index composite for clinical practice: Development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer

Journal of Urology

Volumn 186, Issue 3, 2011, Pages 865-872

  Chang, Peter ^a,b   Szymanski, Konrad M ^e   Dunn, Rodney L ^f   Chipman, Jonathan J ^c   Litwin, Mark S ^g   Nguyen, Paul L ^b   Sweeney, Christopher J ^c   Cook, Robert ^h   Wagner, Andrew A ^a,d   Dewolf, William C ^a,d   Bubley, Glenn J ^a,d   Funches, Renee ^a   Aronovitz, Joseph A ^a   Wei, John T ^e   Sanda, Martin G ^a,d  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h Centra Health   (United States)

Author keywords

outcome assessment (health care); prostatic neoplasms; quality of life; questionnaires

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL PRACTICE; COHORT ANALYSIS; CONSTRUCT VALIDITY; EXPANDED PROSTATE CANCER INDEX FOR CLINICAL PRACTICE; EXTERNAL BEAM RADIOTHERAPY; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SEXUAL HEALTH; URINE INCONTINENCE;

AGED; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 80051543868     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.04.085     Document Type: Article

References (27)

1. M.S. Litwin, R.D. Hays, and A. Fink Quality-of-life outcomes in men treated for localized prostate cancer JAMA 273 1995 129
2. J.T. Wei, R.L. Dunn, and M.S. Litwin Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer Urology 56 2000 899
3. M.S. Litwin, R.D. Hays, and A. Fink The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure Med Care 36 1998 1002
4. K.M. Szymanski, J.T. Wei, and R.L. Dunn Development and validation of an abbreviated version of the Expanded Prostate Cancer Index Composite instrument for measuring health-related quality of life among prostate cancer survivors Urology 76 2010 1245
5. M.J. Barry, F.J. Fowler Jr, and M.P. O'Leary The American Urological Association symptom index for benign prostatic hyperplasia The Measurement Committee of the American Urological Association J Urol 148 1992 1549
6. R.C. Rosen, J.C. Cappelleri, and M.D. Smith Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction Int J Impot Res 11 1999 319
7. M.G. Sanda, R.L. Dunn, and J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250
8. A.C. Spetz, E.L. Zetterlund, and E. Varenhorst Incidence and management of hot flashes in prostate cancer J Support Oncol 1 2003 263
9. A. Dobs, and M.J. Darkes Incidence and management of gynecomastia in men treated for prostate cancer J Urol 174 2005 1737
10. M.R. Smith, M. Goode, and A.L. Zietman Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition J Clin Oncol 22 2004 2546
11. G. Di Lorenzo, S. Perdon, and S. De Placido Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy J Urol 174 2005 2197
12. P.P. Sagnier, C.J. Girman, and M. Garraway International comparison of the community prevalence of symptoms of prostatism in four countries Eur Urol 29 1996 15
13. H. Lepor, W.O. Williford, and M.J. Barry The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group N Engl J Med 335 1996 533
14. J.D. McConnell, R. Bruskewitz, and P. Walsh The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia Finasteride Long-Term Efficacy and Safety Study Group N Engl J Med 338 1998 557
15. J.D. McConnell, C.G. Roehrborn, and O.M. Bautista The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia N Engl J Med 349 2003 2387
16. F.J. Fowler Jr, M.J. Barry, and G. Lu-Yao Patient-reported complications and follow-up treatment after radical prostatectomy The National Medicare Experience: 1988-1990 (updated June 1993) Urology 42 1993 622
17. F. Joly, D. Brune, and J.E. Couette Health-related quality of life and sequelae in patients treated with brachytherapy and external beam irradiation for localized prostate cancer Ann Oncol 9 1998 751
18. G.A. Sonn, N. Sadetsky, and J.C. Presti Differing perceptions of quality of life in patients with prostate cancer and their doctors J Urol 182 2009 2296
19. G. Borghede, and M. Sullivan Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30 Qual Life Res 5 1996 212
20. R.B. Giesler, B.J. Miles, and M.E. Cowen Assessing quality of life in men with clinically localized prostate cancer: development of a new instrument for use in multiple settings Qual Life Res 9 2000 645
21. J.B. Madalinska, M.L. Essink-Bot, and H.J. de Koning Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer J Clin Oncol 19 2001 1619
22. D.P. Smith, M.T. King, and S. Egger Quality of life three years after diagnosis of localised prostate cancer: population based cohort study BMJ 339 2009 b4817
23. Y. Pardo, F. Guedea, and F. Aguiló Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment J Clin Oncol 28 2010 4687
24. A.L. Potosky, J. Legler, and P.C. Albertsen Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study J Natl Cancer Inst 92 2000 1582
25. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969
26. R.C. Chen, J.A. Clark, and J.A. Talcott Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function J Clin Oncol 27 2009 3916
27. J.L. Stanford, Z. Feng, and A.S. Hamilton Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study JAMA 283 2000 354